eTherapeutics Company

eTherapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.

Estimated Revenue: Less than $1M
Funding Status: IPO
Headquarters: Hanborough, Oxfordshire, United Kingdom
Total Funding: 112043919.0
Last Funding Date: 2022-09-30
Investors Number: 2.0
Number Of Exists: Post-IPO Equity
Acquisitions Number: 1
Founded Date: 2003-01-01
Technology: Biotechnology, Health Care, Medical
Industry: Early Drug Development
Last Funding Type: Post-IPO Equity
Investor Type: Company
Investment Stage: N/A
Employee Number: 11-50